| Code | CSB-AP004661HU |
| Abbreviation | Recombinant Human IL23A&IL12B Heterodimer protein (Active) |
| MSDS | |
| Size | $290 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
IL-23 drives Th17 differentiation and sustains inflammatory responses, making it a critical target in autoimmune and tumor immunology research. This recombinant human IL-23 heterodimer (IL-23A aa 20–189 paired with IL-12B aa 23–328) demonstrates confirmed signaling potency with an ED50 of 70–210 ng/mL in a STAT reporter assay using 293F cells, supporting JAK/STAT pathway studies, Th17 polarization assays, and functional screening in antibody development campaigns. The C-terminal 6×His tag enables straightforward purification and oriented immobilization for use as a coating antigen in ELISA or as a reference standard in cytokine detection platforms. Mammalian-expressed to preserve native folding and post-translational modifications, this heterodimer provides greater than 95% purity and endotoxin levels below 1.0 EU/μg, satisfying the stringent criteria required to prevent LPS-driven artifacts in primary immune cell activation and in vivo inflammation models.
There are currently no reviews for this product.